{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T20:02:05Z","timestamp":1779220925920,"version":"3.51.4"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,9,6]],"date-time":"2017-09-06T00:00:00Z","timestamp":1504656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,9,6]],"date-time":"2017-09-06T00:00:00Z","timestamp":1504656000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Alendronate (ALN) is a key therapeutic used to treat glucocorticoid-induced osteoporosis (GIOP), but may induce severe side effects. We showed earlier that plastrum testudinis extracts (PTE) prevented and treated GIOP <jats:italic>in vivo<\/jats:italic>. However, clinically, PTE is seldom used alone. Herein, we reveal the synergistic effect of ALN and PTE can treat GIOP of the rat spine and define the mechanism. Sprague-Dawley rats were randomly assigned to four groups: a vehicle group, a GIOP group, an ALN group, and an ALN+PTE group. Each group was further divided into two experimental phases, including dexamethasone (DXM) intervention and withdrawal. Bone mass, microarchitecture, biomechanics, bone-turnover markers, and histomorphology were evaluated. The mRNA and protein expression levels of CTSK and Runx2 were detemined. We found that ALN+PTE improved bone quantity and quality, bone strength, bone turnover; and mitigated histological damage during glucocorticoid intervention and withdrawal. The therapeutic effect was better than that afforded by ALN alone. ALN+PTE reduced CTSK protein expression, promoted Runx2 mRNA and protein expression to varying extents, and more strongly inhibited bone resorption than did ALN alone. Overall, the synergistic effect mediated by ALN+PTE reversed GIOP during DXM intervention and withdrawal via affecting CTSK and Runx2 expression at mRNA and protein levels.<\/jats:p>","DOI":"10.1038\/s41598-017-10614-5","type":"journal-article","created":{"date-parts":[[2017,8,31]],"date-time":"2017-08-31T08:29:40Z","timestamp":1504168180000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Promotion effect of extracts from plastrum testudinis on alendronate against glucocorticoid-induced osteoporosis in rat spine"],"prefix":"10.1038","volume":"7","author":[{"given":"Hui","family":"Ren","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gengyang","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingjing","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhida","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenhua","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinjing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"De","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhensong","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhidong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaobing","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,9,6]]},"reference":[{"key":"10614_CR1","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/j.jaci.2013.08.040","volume":"132","author":"B Buehring","year":"2013","unstructured":"Buehring, B., Viswanathan, R., Binkley, N. & Busse, W. Glucocorticoid-induced osteoporosis: an update on effects and management. J Allergy Clin Immunol. \n                           132, 1019\u20131030 (2013).","journal-title":"J Allergy Clin Immunol."},{"key":"10614_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/srep37371","volume":"6","author":"MG Rimando","year":"2016","unstructured":"Rimando, M. G. et al. Glucocorticoid receptor and Histone deacetylase 6 mediate the differential effect of dexamethasone during osteogenesis of mesenchymal stromal cells (MSCs). Sci Rep. \n                           6, 37371 (2016).","journal-title":"Sci Rep."},{"key":"10614_CR3","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1016\/S1470-2045(10)70114-5","volume":"11","author":"H Inaba","year":"2010","unstructured":"Inaba, H. & Pui, C. H. Glucocorticoid use in acute lymphoblastic leukaemia. Lancet Oncol. \n                           11, 1096\u20131106 (2010).","journal-title":"Lancet Oncol."},{"key":"10614_CR4","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1016\/S0140-6736(09)60250-6","volume":"373","author":"DM Reid","year":"2009","unstructured":"Reid, D. M. Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): a multicentre, double-blind, double-dummy, randomised controlled trial. Lancet. \n                           373, 1253\u20131263 (2009).","journal-title":"Lancet."},{"key":"10614_CR5","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1056\/NEJM199807303390502","volume":"339","author":"KG Saag","year":"1998","unstructured":"Saag, K. G. et al. Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-Induced Osteoporosis Intervention Study Group. N Engl J Med. \n                           339, 292\u2013299 (1998).","journal-title":"N Engl J Med."},{"key":"10614_CR6","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1002\/jbmr.2708","volume":"31","author":"RA Adler","year":"2016","unstructured":"Adler, R. A. et al. Managing Osteoporosis in Patients on Long-Term Bisphosphonate Treatment: Report of a Task Force of the American Society for Bone and Mineral Research. J Bone Miner Res. \n                           31, 16\u201335 (2016).","journal-title":"J Bone Miner Res."},{"key":"10614_CR7","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1056\/NEJMoa053569","volume":"355","author":"RN de Nijs","year":"2006","unstructured":"de Nijs, R. N. et al. Alendronate or alfacalcidol in glucocorticoid-induced osteoporosis. N Engl J Med. \n                           355, 675\u2013684 (2006).","journal-title":"N Engl J Med."},{"key":"10614_CR8","doi-asserted-by":"crossref","unstructured":"Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis. Arthritis Rheum. 44, 1496\u20131503 (2001).","DOI":"10.1002\/1529-0131(200107)44:7<1496::AID-ART271>3.0.CO;2-5"},{"key":"10614_CR9","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1056\/NEJMoa071408","volume":"357","author":"KG Saag","year":"2007","unstructured":"Saag, K. G. et al. Teriparatide or alendronate in glucocorticoid-induced osteoporosis. N Engl J Med. \n                           357, 2028\u20132039 (2007).","journal-title":"N Engl J Med."},{"key":"10614_CR10","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1111\/j.1365-2184.2007.00431.x","volume":"40","author":"DF Chen","year":"2007","unstructured":"Chen, D. F. et al. Extracts from Plastrum testudinis promote proliferation of rat bone-marrow-derived mesenchymal stem cells. Cell Prolif. \n                           40, 196\u2013212 (2007).","journal-title":"Cell Prolif."},{"key":"10614_CR11","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.biopha.2016.04.068","volume":"82","author":"D Liang","year":"2016","unstructured":"Liang, D. et al. Extracts from plastrum testudinis reverse glucocorticoid-induced spinal osteoporosis of rats via targeting osteoblastic and osteoclastic markers. Biomed Pharmacother. \n                           82, 151\u2013160 (2016).","journal-title":"Biomed Pharmacother."},{"key":"10614_CR12","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1111\/j.1747-0285.2012.01361.x","volume":"79","author":"TT Wang","year":"2012","unstructured":"Wang, T. T., Chen, W., Zeng, H. P. & Chen, D. F. Chemical components in extracts from Plastrum testudinis with proliferation-promoting effects on rat mesenchymal stem cells. Chem Biol Drug Des. \n                           79, 1049\u20131055 (2012).","journal-title":"Chem Biol Drug Des."},{"key":"10614_CR13","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/j.bbrc.2016.07.036","volume":"477","author":"G Shen","year":"2016","unstructured":"Shen, G. et al. Effect of glucocorticoid withdrawal on glucocorticoid inducing bone impairment. Biochem Biophys Res Commun. \n                           477, 1059\u20131064 (2016).","journal-title":"Biochem Biophys Res Commun."},{"key":"10614_CR14","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/j.jaci.2013.08.040","volume":"132","author":"B Buehring","year":"2013","unstructured":"Buehring, B., Viswanathan, R., Binkley, N. & Busse, W. Glucocorticoid-induced osteoporosis: an update on effects and management. J Allergy Clin Immunol. \n                           132, 1019\u20131030 (2013).","journal-title":"J Allergy Clin Immunol."},{"key":"10614_CR15","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1002\/jbmr.2176","volume":"29","author":"BC Silva","year":"2014","unstructured":"Silva, B. C. et al. Trabecular bone score: a noninvasive analytical method based upon the DXA image. J Bone Miner Res. \n                           29, 518\u2013530 (2014).","journal-title":"J Bone Miner Res."},{"key":"10614_CR16","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1002\/jbmr.2325","volume":"30","author":"KE Poole","year":"2015","unstructured":"Poole, K. E. et al. Denosumab rapidly increases cortical bone in key locations of the femur: a 3D bone mapping study in women with osteoporosis. J Bone Miner Res. \n                           30, 46\u201354 (2015).","journal-title":"J Bone Miner Res."},{"key":"10614_CR17","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.compmedimag.2014.06.014","volume":"38","author":"K Klodowski","year":"2014","unstructured":"Klodowski, K. et al. Micro-imaging of implanted scaffolds using combined MRI and micro-CT. Comput Med Imaging Graph. \n                           38, 458\u2013468 (2014).","journal-title":"Comput Med Imaging Graph."},{"key":"10614_CR18","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.jocd.2014.06.001","volume":"18","author":"KM Knapp","year":"2015","unstructured":"Knapp, K. M. et al. Obesity increases precision errors in total body dual-energy x-ray absorptiometry measurements. J Clin Densitom. \n                           18, 209\u2013216 (2015).","journal-title":"J Clin Densitom."},{"key":"10614_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0115595","volume":"9","author":"N Ibrahim","year":"2014","unstructured":"Ibrahim, N. et al. Targeted delivery of lovastatin and tocotrienol to fracture site promotes fracture healing in osteoporosis model: micro-computed tomography and biomechanical evaluation. PLoS One. \n                           9, e115595 (2014).","journal-title":"PLoS One."},{"key":"10614_CR20","first-page":"1396","volume":"72","author":"AM Parfitt","year":"1983","unstructured":"Parfitt, A. M. et al. Relationships between surface, volume, and thickness of iliac trabecular bone in aging and in osteoporosis. Implications for the microanatomic and cellular mechanisms of bone loss. J Clin Invest. \n                           72, 1396\u20131409 (1983).","journal-title":"Implications for the microanatomic and cellular mechanisms of bone loss. J Clin Invest."},{"key":"10614_CR21","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.1007\/s00586-014-3463-z","volume":"23","author":"W Bocker","year":"2014","unstructured":"Bocker, W. et al. Short-term glucocorticoid treatment causes spinal osteoporosis in ovariectomized rats. Eur Spine J. \n                           23, 2437\u20132448 (2014).","journal-title":"Eur Spine J."},{"key":"10614_CR22","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1016\/j.bone.2011.02.005","volume":"48","author":"BB Kalpakcioglu","year":"2011","unstructured":"Kalpakcioglu, B. B., Engelke, K. & Genant, H. K. Advanced imaging assessment of bone fragility in glucocorticoid-induced osteoporosis. Bone. \n                           48, 1221\u20131231 (2011).","journal-title":"Bone."},{"key":"10614_CR23","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1146\/annurev.bioeng.3.1.307","volume":"3","author":"TM Keaveny","year":"2001","unstructured":"Keaveny, T. M., Morgan, E. F., Niebur, G. L. & Yeh, O. C. Biomechanics of trabecular bone. Annu Rev Biomed Eng. \n                           3, 307\u2013333 (2001).","journal-title":"Annu Rev Biomed Eng."},{"key":"10614_CR24","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.bone.2007.08.040","volume":"42","author":"S Gurgul","year":"2008","unstructured":"Gurgul, S., Erdal, N., Yilmaz, S. N., Yildiz, A. & Ankarali, H. Deterioration of bone quality by long-term magnetic field with extremely low frequency in rats. Bone. \n                           42, 74\u201380 (2008).","journal-title":"Bone."},{"key":"10614_CR25","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/GME.0000000000000547","volume":"23","author":"H Ren","year":"2016","unstructured":"Ren, H. et al. Effects of combined ovariectomy with dexamethasone on rat lumbar vertebrae. Menopause. \n                           23, 441\u2013450 (2016).","journal-title":"Menopause."},{"key":"10614_CR26","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.steroids.2015.07.006","volume":"102","author":"H Ren","year":"2015","unstructured":"Ren, H. et al. Variance of spinal osteoporosis induced by dexamethasone and methylprednisolone and its associated mechanism. Steroids. \n                           102, 65\u201375 (2015).","journal-title":"Steroids."},{"key":"10614_CR27","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.eururo.2010.12.006","volume":"59","author":"K Jung","year":"2011","unstructured":"Jung, K., Miller, K., Wirth, M., Albrecht, M. & Lein, M. Bone turnover markers as predictors of mortality risk in prostate cancer patients with bonemetastases following treatment with zoledronic acid. Eur Urol. \n                           59, 604\u2013612 (2011).","journal-title":"Eur Urol."},{"key":"10614_CR28","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1038\/leu.2013.267","volume":"28","author":"E Terpos","year":"2014","unstructured":"Terpos, E. et al. VTD consolidation, without bisphosphonates, reduces bone resorption and is associated with a very low incidence of skeletal-related events in myeloma patients post ASCT. Leukemia. \n                           28, 928\u2013934 (2014).","journal-title":"Leukemia."},{"key":"10614_CR29","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1359\/jbmr.090315","volume":"24","author":"RR Recker","year":"2009","unstructured":"Recker, R. R. et al. Comparative effects of teriparatide and strontium ranelate on bone biopsies and biochemical markers of bone turnover in postmenopausal women with osteoporosis. J Bone Miner Res. \n                           24, 1358\u20131368 (2009).","journal-title":"J Bone Miner Res."},{"key":"10614_CR30","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.bone.2014.06.022","volume":"66","author":"ME McGee-Lawrence","year":"2014","unstructured":"McGee-Lawrence, M. E. et al. Runx2 is required for early stages of endochondral bone formation but delays final stages of bone repair in Axin2-deficient mice. Bone. \n                           66, 277\u2013286 (2014).","journal-title":"Bone."},{"key":"10614_CR31","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1016\/j.cell.2015.05.029","volume":"161","author":"J Wei","year":"2015","unstructured":"Wei, J. et al. Glucose Uptake and Runx2 Synergize to Orchestrate Osteoblast Differentiation and Bone Formation. Cell. \n                           161, 1576\u20131591 (2015).","journal-title":"Cell."},{"key":"10614_CR32","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/S0140-6736(10)62349-5","volume":"377","author":"TD Rachner","year":"2011","unstructured":"Rachner, T. D., Khosla, S. & Hofbauer, L. C. Osteoporosis: now and the future. Lancet. \n                           377, 1276\u20131287 (2011).","journal-title":"Lancet."},{"key":"10614_CR33","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.bone.2014.05.016","volume":"66","author":"P Garnero","year":"2014","unstructured":"Garnero, P. New developments in biological markers of bone metabolism in osteoporosis. Bone. \n                           66, 46\u201355 (2014).","journal-title":"Bone."},{"key":"10614_CR34","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1126\/science.1150110","volume":"319","author":"M Asagiri","year":"2008","unstructured":"Asagiri, M. et al. Cathepsin K-dependent toll-like receptor 9 signaling revealed in experimental arthritis. Science. \n                           319, 624\u2013627 (2008).","journal-title":"Science."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-10614-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-10614-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-10614-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T10:18:38Z","timestamp":1671790718000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-10614-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,6]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["10614"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-10614-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,6]]},"assertion":[{"value":"3 February 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"10617"}}